Company's Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer
FRAMINGHAM, MA / ACCESSWIRE / May 10, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...
Xenetic Biosciences: Q1 Earnings Snapshot
Xenetic Biosciences, Inc. (NASDAQ:XBIO) shares began Friday negative, as the company, based out of Framingham, ...
Xenetic Biosciences: Q3 Earnings Snapshot
FRAMINGHAM, MA / ACCESSWIRE / November 10, 2023 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...
- Live video webcast interactive Q&A with participating companies -
Live moderated webcast with Jeffrey Eisenberg, Chief Executive Officer of Xenetic Biosciences on Tuesday, October 24th at 1:00 PM ET
Xenetic Biosciences: Q2 Earnings Snapshot
Xenetic Biosciences: Q1 Earnings Snapshot